Difference between revisions of "About-cancer/treatment/drugs/lenalidomide"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Lenalidomide == | + | == Lenalidomide == <!--T:1--> |
| + | <!--T:2--> | ||
This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
Revlimid | Revlimid | ||
| + | <!--T:5--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:6--> | ||
Yes | Yes | ||
| + | <!--T:7--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:8--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:9--> | ||
Lenalidomide is approved to treat: | Lenalidomide is approved to treat: | ||
| + | <!--T:10--> | ||
*'''Anemia''' caused by certain types of myelodysplastic syndromes. It is used in adults. | *'''Anemia''' caused by certain types of myelodysplastic syndromes. It is used in adults. | ||
| + | <!--T:11--> | ||
*'''Follicular lymphoma''' in adults who have already received other treatment. | *'''Follicular lymphoma''' in adults who have already received other treatment. | ||
| + | <!--T:12--> | ||
*'''Mantle cell lymphoma''' in adults whose disease recurred (came back) or got worse after two other treatments,including bortezomib. | *'''Mantle cell lymphoma''' in adults whose disease recurred (came back) or got worse after two other treatments,including bortezomib. | ||
| + | <!--T:13--> | ||
*'''Marginal zone lymphoma''' in adults who have already received other treatment. It is used with rituximab. | *'''Marginal zone lymphoma''' in adults who have already received other treatment. It is used with rituximab. | ||
| + | <!--T:14--> | ||
*'''Multiple myeloma''' in adults. It is given with dexamethasone. It is also used alone as maintenance therapy in adults *who received an autologous stem cell transplant. | *'''Multiple myeloma''' in adults. It is given with dexamethasone. It is also used alone as maintenance therapy in adults *who received an autologous stem cell transplant. | ||
| + | <!--T:15--> | ||
Lenalidomide is only available as part of a special program called Revlimid REMS (Risk Evaluation and Mitigation StrategiesExit Disclaimer). | Lenalidomide is only available as part of a special program called Revlimid REMS (Risk Evaluation and Mitigation StrategiesExit Disclaimer). | ||
| + | <!--T:16--> | ||
Lenalidomide is also being studied in the treatment of other conditions and types of cancer. | Lenalidomide is also being studied in the treatment of other conditions and types of cancer. | ||
| + | <!--T:17--> | ||
'''More About Lenalidomide''' | '''More About Lenalidomide''' | ||
| + | <!--T:18--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:19--> | ||
MedlinePlus Information on Lenalidomide - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Lenalidomide - A lay language summary of important information about this drug that may include the following: | ||
| + | <!--T:20--> | ||
*warnings about this drug, | *warnings about this drug, | ||
| + | <!--T:21--> | ||
*what this drug is used for and how it is used, | *what this drug is used for and how it is used, | ||
| + | <!--T:22--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
| + | <!--T:23--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
| + | <!--T:24--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
| + | <!--T:25--> | ||
*possible side effects. | *possible side effects. | ||
| + | <!--T:26--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
| + | <!--T:27--> | ||
'''Research Results and Related Resources''' | '''Research Results and Related Resources''' | ||
| + | <!--T:28--> | ||
Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer | Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer | ||
| + | <!--T:29--> | ||
FDA Approves New Use for Lenalidomide in Multiple Myeloma | FDA Approves New Use for Lenalidomide in Multiple Myeloma | ||
| + | <!--T:30--> | ||
Three-Drug Combination Extends Survival for Patients with Multiple Myeloma | Three-Drug Combination Extends Survival for Patients with Multiple Myeloma | ||
| + | <!--T:31--> | ||
Three-Drug Combination Benefits Some Patients With Relapsed Multiple Myeloma | Three-Drug Combination Benefits Some Patients With Relapsed Multiple Myeloma | ||
| + | <!--T:32--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:33--> | ||
Find Clinical Trials for Lenalidomide - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Lenalidomide - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:34--> | ||
'''Important''': The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important''': The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> | ||
Latest revision as of 21:33, 29 October 2019
Lenalidomide
This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Revlimid
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Lenalidomide is approved to treat:
- Anemia caused by certain types of myelodysplastic syndromes. It is used in adults.
- Follicular lymphoma in adults who have already received other treatment.
- Mantle cell lymphoma in adults whose disease recurred (came back) or got worse after two other treatments,including bortezomib.
- Marginal zone lymphoma in adults who have already received other treatment. It is used with rituximab.
- Multiple myeloma in adults. It is given with dexamethasone. It is also used alone as maintenance therapy in adults *who received an autologous stem cell transplant.
Lenalidomide is only available as part of a special program called Revlimid REMS (Risk Evaluation and Mitigation StrategiesExit Disclaimer).
Lenalidomide is also being studied in the treatment of other conditions and types of cancer.
More About Lenalidomide
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Lenalidomide - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer
FDA Approves New Use for Lenalidomide in Multiple Myeloma
Three-Drug Combination Extends Survival for Patients with Multiple Myeloma
Three-Drug Combination Benefits Some Patients With Relapsed Multiple Myeloma
Clinical Trials Accepting Patients
Find Clinical Trials for Lenalidomide - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
